K-ras mutations are frequently seen in some of tissues such as colon, lung and pancreas; and recent studies have shown that genetic alterations of ras oncogenes play a crucial role in early carcinogenic events (5, 6) and the trigger of ovarian cancer. This evidence concerns the gene KRAS and ovarian carcinoma.